Figure 3.
Flow cytometric analysis of the expression of BMDC surface antigens at different culture times. (A) CD11c 21.6%, CD40 12.2%, CD80 14.1%, CD86 8.4%, MHC-II 3.5%; (B) CD11c 62.1%, CD40 29.0%, CD80 54.1%, CD86 21.7%, MHC-II 24.8%, (C) CD11c 63.7%, CD40 65.7%, CD80 72.2%, CD86 57.5%, MHC-II 45.2%.